Page 3 - Les meilleurs doctors traitant la maladie suivante : Ostéosarcome - TOP -71 des médecins

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Le Dr Netanel Meusher dirige l'équipe de traitement du cancer des os au centre médical Rambam.

• Spécialiste du traitement du cancer des os
• Chef de service dans un hôpital israélien majeur

Chef du département d'hématologie pédiatrique – Sergei Postovskiy est spécialisé dans la chirurgie de l'ostéosarcome pédiatrique au centre médical Rambam.

• Formé pour les cas pédiatriques spécifiques dans un service spécialisé
• Se concentrer sur les techniques de chirurgie hématologique pour les jeunes patients
• Opérer dans le cadre d'un département dédié pour des protocoles cohérents
• Prendre en charge les besoins chirurgicaux pédiatriques courants et complexes

Oncologue pédiatrique de renommée internationale – Le professeur Ben-Harush dirige le département de pédiatrie de l'hôpital pour enfants Ruth Rappaport, Rambam.

• Se spécialiser en oncologie pédiatrique et en greffe de moelle osseuse
• Récipiendaire de la distinction de Chevalier de la Légion d'Honneur
• Nommé parmi les médecins les plus dévoués au monde par l'Association Médicale Mondiale
• Membre de groupes d'oncologie pédiatrique aux États-Unis et en Europe

Chirurgien orthopédiste spécialisé en endoprothèse – le remplacement articulaire artificiel souvent nécessaire après une chirurgie complexe de tumeur osseuse.

• Expert en reconstruction de membres et en chirurgie d'exérèse tumorale
• Spécialisé dans le remplacement articulaire pour les cancers musculo-squelettiques
• Basé au centre médical Assuta

Médecin-chef du centre d'oncologie du centre médical Assuta – spécialisé dans le traitement de l'ostéosarcome.

• Oncologue de renom dans un établissement médical de premier plan
• Vaste expérience dans la gestion de cas oncologiques complexes
• Accent mis sur les approches de traitement personnalisées

Le Pr Assoc. Murat Ayhan est spécialisé dans les traitements avancés des cancers des os, y compris l'immunothérapie innovante et les thérapies ciblées à l'hôpital Liv Vadistanbul.

• Professeur associé d'oncologie médicale avec des recherches approfondies sur les traitements du cancer
• Participant actif à des essais cliniques internationaux pour les cancers du sein, du poumon et colorectal
• Auteur de plusieurs publications médicales et chapitres de livres sur l'oncologie
• Membre de la Société européenne d'oncologie médicale (ESMO) et de la Société turque d'oncologie médicale (TTOD)

Spécialisé en radio-oncologie à l'Université de Marmara – une institution médicale de premier plan en Turquie.

• Suivre une formation rigoureuse en radio-oncologie de 2012 à 2016
• Être diplômé de la Faculté de Médecine de l'Université de Marmara (programme en anglais)
• Travailler à l'Hôpital Emsey, un établissement de santé moderne

Le professeur agrégé Dr Emrah Eraslan est spécialisé en oncologie médicale avec une expertise en ostéosarcome à l'hôpital privé Koru Ankara.

• Plus de 15 ans d'expérience en médecine interne et oncologie médicale
• Formé à l'hôpital de formation et de recherche en oncologie Dr Abdurrahman Yurtaslan d'Ankara
• Publication de nombreux articles de recherche contribuant au domaine de l'oncologie
• Actuel professeur agrégé avec une pratique clinique active

Le Dr Borde a traité plus de 30 000 examens TEP et 1 000 patients atteints de cancer de la thyroïde au HCG Manavata Cancer Centre.

• 12 ans d'expérience en médecine nucléaire
• Se spécialiser dans les thérapies à l'iode radioactif et au Lu-177 RN
• Maîtriser tous les types de scanners nucléaires et de TEP-TDM
• Publier des articles dans diverses revues médicales